Логотип НМИЦССХ им. А.Н. Бакулева Журнал «Новости сердечно-сосудистой хирургии»






Митральный стеноз


Авторы: Амирагов Р.И., Асатрян Т. В., Куц Э. В., Мироненко В. А., Муратов Р. М., Скопин И. И.

Организация:
ФГБУ «НМИЦ ССХ им. А.Н. Бакулева» Минздрава России

Раздел: Клинические рекомендации

УДК: 616.126.42-007.271

Библиографическая ссылка: Новости сердечно-сосудистой хирургии. 2017; (3-4): 163-181

Цитировать как: Амирагов Р.И., Асатрян Т. В., Куц Э. В., Мироненко В. А., Муратов Р. М., Скопин И. И.. Митральный стеноз. Новости сердечно-сосудистой хирургии. 2017; (3-4): 163-181. DOI:

Полнотекстовая версия:  

Аннотация

Полный текст клинических рекомендаций. Утверждены Ассоциацией сердечно-сосудистых хирургов России в 2016 году.

Литература

1. Schwartz B., Facklam R.R., Breiman R.F. Changing epidemiology of group A streptococcal infection in the USA. Lancet. 1990; 336: 1167–71. 2. Bisno A.L. Group A streptococcal infections and acute rheumatic fever. N. Engl. J. Med. 1991; 325: 783–93. 3. Wood P. An appreciation of mitral stenosis, I: clinical features. Br. Med. J. 1954; 4870: 1051–63. 4. Rowe J.C., Bland E.F., Sprague H.B., White P.D. The course of mitral stenosis without surgery: ten- and twenty-year perspectives. Ann. Intern. Med. 1960; 52: 741–9. 5. Olesen K.H. The natural history of 271 patients with mitral stenosis under medical treatment. Br. Heart J. 1962; 24: 349–57. 6. Roberts W.C., Perloff J.K. Mitral valvular disease: a clinicopathologic survey of the conditions causing the mitral valve to function abnormally. Ann. Intern. Med. 1972; 77: 939–75. 7. Rusted I.E., Scheifley C.H., Edwards J.E. Studies of the mitral valve, II: certain anatomic features of the mitral valve and associated structures in mitral stenosis. Circulation. 1956; 14: 398–406. 8. Braunwald E., Moscovitz H.L., Mram S.S. et al. The hemodynamics of the left side of the heart as studied by simultaneous left atrial, left ventricular, and aortic pressures; particular reference to mitral stenosis. Circulation. 1955; 12: 69–81. 9. Hugenholtz P.G., Ryan T.J., Stein S.W., Belmann W.H. The spectrum of pure mitral stenosis: hemodynamic studies in relation to clinical disability. Am. J. Cardiol. 1962; 10: 773–84. 10. Kasalicky J., Hurych J., Widimsky J., Dejdar R., Metys R., Stanek V. Left heart haemodynamics at rest and during exercise in patients with mitral stenosis. Br. Heart J. 1968; 30: 188–95. 11. Snopek G., Pogorzelska H., Rywik T.M., Browarek A., Janas J., Korewicki J. Usefulness of endothelin-1 concentration in capillary blood in patients with mitral stenosis as a predictor of regression of pulmonary hypertension after mitral valve replacement or valvuloplasty. Am. J. Cardiol. 2002; 90: 188–9. 12. Gorlin R. The mechanism of the signs and symptoms of mitral valve disease. Br. Heart J. 1954; 16: 375–80. 13. Wood P. An appreciation of mitral stenosis, II: investigations and results. Br. Med. J. 1954; 4871: 1113–24. 14. Halperin J.L., Rothlauf E.B., Brooks K.M., Mindich B.P., Ambrose J.A., Teichholz L.E. Effect of nitroglycerin on the pulmonary venous gradient in patients after mitral valve replacement. J. Am. Coll. Cardiol. 1985; 5: 34–9. 15. Halperin J.L., Rothlauf E.B., Brooks K.M., Mindich B.P., Ambrose J.A. Effect of nitroglycerin during hemodynamic estimation of valve orifice in patients with mitral stenosis. J. Am. Coll. Cardiol. 1987; 10: 342–8. 16. Selzer A., Cohn K.E. Natural history of mitral stenosis: a review. Circulation. 1972; 45: 878–90. 17. Munoz S., Gallardo J., Diaz-Gorrin J.R., Medina O. Influence of surgery on the natural history of rheumatic mitral and aortic valve disease. Am. J. Cardiol. 1975; 35: 234–42. 18. Ward C., Hancock B.W. Extreme pulmonary hypertension caused by mitral valve disease: natural history and results of surgery. Br. Heart J. 1975; 37: 74–8. 19. Carroll J.D., Feldman T. Percutaneous mitral balloon valvotomy and the new demographics of mitral stenosis. JAMA. 1993; 270: 1731–6. 20. Tuzcu E.M., Block P.C., Griffin B.P., Newell J.B., Palacios I.F. Immediate and longterm outcome of percutaneous mitral valvotomy inpatients 65 years and older. Circulation. 1992; 85: 963–71. 21. Dubin A.A., March H.W., Cohn K., Selzer A. Longitudinal hemodynamic and clinical study of mitral stenosis. Circulation. 1971; 44: 381–9. 22. Gordon S.P., Douglas P.S., Come P.C., Manning W.J. Two dimensional and Doppler echocardiographic determinants of the natural history of mitral valve narrowing in patients with rheumatic mitral stenosis: implications for follow-up. J. Am. Coll. Cardiol. 1992; 19: 968–73. 23. Craige E. Phonocardiographic studies in mitral stenosis. N. Engl. J. Med. 1957; 257: 650–4. 24. Henry W.L., Griffith J.M., Michaelis L.L., McIntosh C.L., Morrow A.G., Epstein S.E. Measurement of mitral orifice area in patients with mitral valve disease by real-time, two-dimensional echocardiography. Circulation. 1975; 51: 827–31. 25. Nichol P.M., Gilbert B.W., Kisslo J.A. Two-dimensional echocardiographic assessment of mitral stenosis. Circulation. 1977; 55: 120–8. 26. Wann L.S., Weyman A.E., Feigenbaum H., Dillon J.C., Johnston K.W., Eggleton R.C. Determination of mitral valve area by cross-sectional echocardiography. Ann. Intern. Med. 1978; 88: 337–41. 27. Martin R.P., Rakowski H., Kleiman J.H., Beaver W., London E., Popp R.L. Reliability and reproducibility of two dimensional echocardiograph measurement of the stenotic mitral valve orifice area. Am. J. Cardiol. 1979; 43: 560–8. 28. Hatle L., Brubakk A., Tromsdal A., Angelsen B. Noninvasive assessment of pressure drop in mitral stenosis by Doppler ultrasound. Br. Heart J. 1978; 40: 131–40. 29. Reid C.L., McKay C.R., Chandraratna P.A., Kawanishi D.T., Rahimtoola S.H. Mechanisms of increase in mitral valve area and influence of anatomic features in double-balloon, catheter balloon valvuloplasty in adults with rheumatic mitral stenosis: a Doppler and two-dimensional echocardiographic study. Circulation. 1987; 76: 628–36. 30. Rediker D.E., Block P.C., Abascal V.M., Palacios I.F. Mitral balloon valvuloplasty for mitral restenosis after surgical commissurotomy. J. Am. Coll. Cardiol. 1988; 11: 252–6. 31. Fatkin D., Roy P., Morgan J.J., Feneley M.P. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J. Am. Coll. Cardiol. 1993; 21: 390–7. 32. Iung B., Cormier B., Ducimetiere P. et al. Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J. Am. Coll. Cardiol. 1996; 27: 407–14. 33. Cannan C.R., Nishimura R.A., Reeder G.S. et al. Echocardiographic assessment of commissural calcium: a simple predictor of outcomeafter percutaneous mitral balloon valvotomy. J. Am. Coll. Cardiol. 1997; 29: 175–80. 34. Reid C.L., Chandraratna P.A., Kawanishi D.T, Kotlewski A., Rahimtoola S.H. Influence of mitral valve morphology on double-balloon catheter balloon valvuloplasty in patients with mitral stenosis: analysis of factors predicting immediate and 3-month results. Circulation. 1989; 80: 515–24. 35. Wilkins G.T., Weyman A.E., Abascal V.M., Block P.C., Palacios I.F. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br. Heart J. 1988; 60: 299–308. 36. Holen J., Aaslid R., Landmark K., Simonsen S. Determination of pressure gradient in mitral stenosis with a non-invasive ultrasound Doppler technique. Acta Med. Scand. 1976; 199: 455–60. 37. Hatle L., Angelsen B., Tromsdal A. Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation. 1979; 60: 1096–104. 38. Nakatani S., Masuyama T., Kodama K., Kitabatake A., Fujii K., Kamada T. Value and limitations of Doppler echocardiography in the quantification of stenotic mitral valve area: comparison of the pressure half-time and the continuity equation methods. Circulation. 1988; 77: 78–85. 39. Thomas J.D., Wilkins G.T., Choong C.Y. et al. Inaccuracy of mitral pressure halftime immediately after percutaneous mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular compliance. Circulation. 1988; 78: 980–93. 40. Flachskampf F.A., Weyman A.E., Guerrero J.L., Thomas J.D. Influence of orifice geometry and flow rate on effective valve area: an invitro study. J. Am. Coll. Cardiol. 1990; 15: 1173–80. 41. Currie P.J., Seward J.B., Chan K.L. et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Dopplercatheterization study in 127 patients. J. Am. Coll. Cardiol. 1985; 6: 750–6. 42. Himelman R.B., Stulbarg M., Kircher B. et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease. Circulation. 1989; 79: 863–71. 43. Tamai J., Nagata S., Akaike M. et al. Improvement in mitral flow dynamics during exercise after percutaneous transvenous mitral commissurotomy: noninvasive evaluation using continuous wave Doppler technique. Circulation. 1990; 81: 46–51. 44. Leavitt J.I., Coats M.H., Falk R.H. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study. J. Am. Coll. Cardiol. 1991; 17: 1520–6. 45. Cheriex E.C., Pieters F.A, Janssen J.H., de Swart H., Palmans-Meulemans A. Value of exercise Doppler-echocardiography inpatients with mitral stenosis. Int. J. Cardiol. 1994; 45: 219–26. 46. Nishimura R.A., Rihal C.S., Tajik A.J., Holmes D.R. Jr. Accurate measurement of the transmitral gradient in patients with mitral stenosis: a simultaneous catheterization and Doppler echocardiographic study. J. Am. Coll. Cardiol. 1994; 24: 152–8. 47. Okay T., Deligonul U., Sancaktar O., Kozan O. Contribution of mitral valve reserve capacity to sustained symptomatic improvement after balloon valvulotomy in mitral stenosis: implications for restenosis. J. Am. Coll. Cardiol. 1993; 22: 1691–6. 48. Nakhjavan F.K., Katz M.R., Maranhao V., Goldberg H. Analysis of influence of catecholamine and tachycardia during supine exercise in patients with mitral stenosis and sinus rhythm. Br. Heart J. 1969; 31: 753–61. 49. Bhatia M.L., Shrivastava S., Roy S.B. Immediate haemodynamic effects of a beta adrenergic blocking agent-propranolo in mitral stenosis at fixed heart rates. Br. Heart J. 1972; 34: 638–4. 50. Alan S., Ulgen M.S., Ozdemir K., Keles T., Toprak N. Reliability and efficacy of metoprolol and diltiazem in patients having mild to moderate mitral stenosis with sinus rhythm. Angiology. 2002; 53: 575–81. 51. Cieslewicz G., Juszczyk G., Foremny J. et al. Inhaled corticosteroid improves bronchial reactivity and decreases symptoms in patients with mitral stenosis. Chest. 1998; 114: 1070–4. 52. Beiser G.D., Epstein S.E., Stampfer M., Robinson B., Braunwald E. Studies on digitalis, XVII: effects of ouabain on the hemodynamic response to exercise in patients with mitral stenosis in normal sinus rhythm. N. Engl. J. Med. 1968; 278: 131–7. 53. Coulshed N., Epstein E.J., McKendrick C.S., Galloway R.W., Walker E. Systemic embolism in mitral valve disease. Br. Heart J. 1970; 32: 26–34. 54. Abernathy W.S., Willis P.W. III. Thromboembolic complications of rheumatic heart disease. Cardiovasc. Clin. 1973; 5: 131–75. 55. Daley R., Mattingly T.W., Holt C.L., Bland E.F., White P.D. Systemic arterial embolism in rheumatic heart disease. Am. Heart J. 1951; 42: 566–81. 56. Laupacis A., Albers G., Dunn M., Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest. 1992; 102: 426S–33S. 57. Manning W.J., Silverman D.I., Keighley C.S., Oettgen P., Douglas P.S. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J. Am. Coll. Cardiol. 1995; 25: 1354–61. 58. Adams G.F., Merrett J.D., Hutchinson W.M., Pollock A.M. Cerebralembolism and mitral stenosis: survival with and without anticoagulants. J. Neurol. Neurosurg. Psych. 1974; 37: 378–83. 59. Krasuski R.A., Assar M.D., Wang A. et al. Usefulness of percutaneous balloon mitral commissurotomy in preventing the development of atrial fibrillation in patients with mitral stenosis. Am. J. Cardiol. 2004; 93: 936–9. 60. Caplan L.R., D'Cruz I., Hier D.B., Reddy H., Shah S. Atrial size, atrial fibrillation, and stroke. Ann. Neurol. 1986; 19: 158–61. 61. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation. 1991; 84: 527–39. 62. Ezekowitz M.D., Bridgers S.L., James K.E. et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N. Engl. J. Med. 1992; 327: 1406–12. 63. Levine HJ, Pauker SG, Eckman MH. Antithrombotic therapy in valvular heart disease. Chest. 1995; 108: 360S–70S. 64. Gohlke-Barwolf C., Acar J., Oakley C. et al. Guidelines for prevention of thromboembolic events in valvular heart disease: Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 1995; 16: 1320–30. 65. Kellogg F., Liu C.K., Fishman I.W., Larson R. Systemic and pulmonary emboli before and after mitral commissurotomy. Circulation. 1961; 24: 263–6. 66. Deverall P.B., Olley P.M., Smith D.R., Watson D.A., Whitaker W. Incidence of systemic embolism before and after mitral valvotomy. Thorax. 1968; 23: 530–6. 67. Chiang C.W., Lo S.K., Ko Y.S., Cheng N.J., Lin P.J., Chang C.H. Predictors of systemic embolism in patients with mitral stenosis: aprospective study. Ann. Intern. Med. 1998; 128: 885–9. 68. Harvey R.M., Ferrer I., Samet P. et al. Mechanical and myocardial factors in rheumatic heart disease with mitral stenosis. Circulation. 1955; 11: 531–51. 69. Aviles R.J., Nishimura R.A., Pellikka P.A., Andreen K.M., Holmes D.R. Jr. Utility of stress Doppler echocardiography in patients undergoing percutaneous mitral balloon valvotomy. J. Am. Soc. Echocardiogr. 2001; 14: 676–81. 70. Wu Z.K., Sun P.W., Zhang X., Zhong F.T., Tong C.W., Lu K. Superiority of mitral valve replacement with preservation of subvalvular structure to conventional replacement in severe rheumatic mitral valve disease: a modified technique and results of one-year follow up. J. Heart Valve Dis. 2000; 9: 616–22. 71. David T.E. Artificial chordae. Semin. Thorac. Cardiovasc. Surg. 2004; 16: 161–8. 72. Feldman T., Foster E., Glower D.D., Kar S., Rinaldi M.J., Fail P.S. et al. EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N. Engl. J. Med. 2011; 364: 1395–1406. 73. Franzen O., Baldus S., Rudolph V., Meyer S., Knap M., Koschyk D. et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur. Heart J. 2010; 31: 1373–81. 74. Feldman T. Hemodynamic results, clinical outcome, and complications of Inoue balloon mitral valvotomy. Cathet. Cardiovasc. Diagn. 1994; 85 Suppl 2: 2–7. 75. Cohen D.J., Kuntz R.E., Gordon S.P. et al. Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. N. Engl. J. Med. 1992; 327: 1329–35. 76. Complications and mortality of percutaneous balloon mitral commissurotomy: a report from the National Heart, Lung, and BloodInstitute Balloon Valvuloplasty Registry. Circulation. 1992; 85: 2014–24. 77. Orrange S.E., Kawanishi D.T., Lopez B.M., Curry S.M., Rahimtoola S.H. Actuarial outcome after catheter balloon commissurotomy in patients with mitral stenosis. Circulation. 1997; 95: 382–9. 78. Cribier A., Eltchaninoff H., Koning R. et al. Percutaneous mechanical mitral commissurotomy with a newly designed metallic valvulotome: immediate results of the initial experience in 153 patients. Circulation. 1999; 99: 793–9. 79. Multicenter experience with balloon mitral commissurotomy: NHLBI Balloon Valvuloplasty Registry Report on immediate and 30-day follow- up results: the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry Participants. Circulation. 1992; 85: 448–61. 80. Dean L.S., Mickel M., Bonan R. et al. Four-year follow-up of patients undergoing percutaneous balloon mitral commissurotomy: a report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry. J. Am. Coll. Cardiol. 1996; 28: 1452–7. 81. Iung B., Garbarz E., Michaud P. et al. Late results of percutaneous mitral commissurotomy in a series of 1024 patients: analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. Circulation. 1999; 99: 3272–8. 82. Kang D.H., Park S.W., Song J.K. et al. Long-term clinical and echocardiographic outcome of percutaneous mitral valvuloplasty: randomized comparison of Inoue and double-balloon techniques. J. Am. Coll. Cardiol. 2000; 35: 169–5. 83. Tokmakoglu H., Vural K.M., Ozatik M.A., Cehreli S., Sener E., Tasdemir O. Closed commissurotomy versus balloon valvuloplasty for rheumatic mitral stenosis. J. Heart Valve Dis. 2001; 10: 281–7. 84. Palacios I.F., Sanchez P.L., Harrell L.C., Weyman A.E., Block P.C. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predictlong-term outcome. Circulation. 2002; 105: 1465–71. 85. Palacios I.F., Tuzcu M.E., Weyman A.E., Newell J.B., Block P.C. Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy. Circulation. 1995; 91: 671–6. 86. Hernandez R., Banuelos C., Alfonso F. et al. Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation. 1999; 99: 1580–6. 87. Patel J.J., Shama D., Mitha A.S. et al. Balloon valvuloplasty versus closed commissurotomy for pliable mitral stenosis: a prospective hemodynamic study. J. Am. Coll. Cardiol. 1991; 18: 1318–22. 88. Turi Z.G., Reyes V.P., Raju B.S. et al. Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis: a prospective, randomized trial. Circulation. 1991; 83: 1179–85. 89. Arora R., Nair M., Kalra G.S., Nigam M., Khalilullah M. Immediate and long-term results of balloon and surgical closed mitral valvotomy: a randomized comparative study. Am. Heart J. 1993; 125: 1091–4. 90. Reyes V.P., Raju B.S., Wynne J. et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N. Engl. J. Med. 1994; 331: 961–7. 91. Ben Farhat M., Ayari M., Maatouk F. et al. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow- up results of a randomized trial. Circulation. 1998; 97: 245–50. 92. Cotrufo M., Renzulli A., Ismeno G. et al. Percutaneous mitral commissurotomy versus open mitral commissurotomy: a comparativestudy. Eur. J. Cardiothorac. Surg. 1999; 15: 646–51. 93. Padial L.R., Freitas N., Sagie A. et al. Echocardiography can predict which patients will develop severe mitral regurgitation after percutaneous mitral valvulotomy. J. Am. Coll. Cardiol. 1996; 27: 1225–31. 94. Silaruks S., Thinkhamrop B., Tantikosum W., Wongvipaporn C., Tatsanavivat P., Klungboonkrong V. A prognostic model for predicting the disappearance of left atrial thrombi among candidates for percutaneous transvenous mitral commissurotomy. J. Am. Coll. Cardiol. 2002; 39: 886–91. 95. Padial L.R., Abascal V.M., Moreno P.R., Weyman A.E., Levine R.A., Palacios I.F. Echocardiography can predict the development of severe mitral regurgitation after percutaneous mitral valvuloplasty by the Inoue technique. Am. J. Cardiol. 1999; 83: 1210–3. 96. Yasu T., Katsuki T., Ohmura N. et al. Delayed improvement in skeletal muscle metabolism and exercise capacity in patients with mitral stenosis following immediate hemodynamic amelioration by percutaneous transvenous mitral commissurotomy. Am. J. Cardiol. 1996; 77: 492–7. 97. McKay C.R., Kawanishi D.T., Kotlewski A. et al. Improvement in exercise capacity and exercise hemodynamics 3 months after double balloon, catheter balloon valvuloplasty treatment of patients with symptomatic mitral stenosis. Circulation. 1988; 77: 1013–21. 98. Dalen J.E., Matloff J.M., Evans G.L. et al. Early reduction of pulmonary vascular resistance after mitral-valve replacement. N. Engl. J. Med. 1967; 277: 387–94. 99. Mahoney P.D., Loh E., Blitz L.R., Herrmann H.C. Hemodynamic effects of inhaled nitric oxide in women with mitral stenosis and pulmonary hypertension. Am. J. Cardiol. 2001; 87: 188–92. 100. Rihal C.S., Schaff H.V., Frye R.L., Bailey K.R., Hammes L.N., Holmes D.R. Jr. Long-term follow-up of patients undergoing closed transventricular mitral commissurotomy: a useful surrogate for percutaneous balloon mitral valvuloplasty? J. Am. Coll. Cardiol. 1992; 20: 781–6. 101. Higgs L.M., Glancy D.L., O'Brien K.P., Epstein S.E., Morrow AG. Mitral restenosis: an uncommon cause of recurrent symptoms following mitral commissurotomy. Am. J. Cardiol. 1970; 26: 34–7. 102. Dahl J.C., Winchell P., Borden C.W. Mitral stenosis: a longterm postoperative follow-up. Arch. Intern. Med. 1967: 119: 92–7. 103. Abascal V.M., Wilkins G.T., Choong C.Y. et al. Echocardiographic evaluation of mitral valve structure and function in patients followed for at least 6 months after percutaneous balloon mitral valvuloplasty. J. Am. Coll. Cardiol. 1988; 12: 606–15. 104. Jang I.K., Block P.C., Newell J.B., Tuzcu E.M., Palacios I.F. Percutaneous mitral balloon valvotomy for recurrent mitral stenosis after surgical commissurotomy. Am. J. Cardiol. 1995; 75: 601–5. 105. Rangel A., Chavez E., Murillo H., Ayala F. Immediate results of the Inoue mitral valvotomy in patients with previous surgical mitral commissurotomy: preliminary report. Arch. Med. Res. 1998; 29: 159–63. 106. Gupta A., Lokhandwala Y.Y., Satoskar P.R., Salvi V.S. Balloon mitral valvotomy in pregnancy: maternal and fetal outcomes. J. Am. Coll. Surg. 1998; 187: 409–15. 107. Shaw T.R., Sutaria N., Prendergast B. Clinical and haemodynamic profiles of young, middle aged, and elderly patients with mitral stenosis undergoing mitral balloon valvotomy. Heart. 2003; 89: 1430–6. 108. Dajani A., Taubert K., Ferrieri P., Peter G., Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995; 96: 758–64.